KLAUSNER ARTHUR J
SEC Form 4 insider trading activity
KLAUSNER ARTHUR J has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Dec 19, 2025.
On the most recent filing, KLAUSNER ARTHUR J is listed as Director at Monopar Therapeutics. Inside the rolling window, KLAUSNER ARTHUR J reported no open-market purchases and 1 open-market sale totaling $344K in MNPR.
Companies traded
Other insiders at MNPR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$344K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has KLAUSNER ARTHUR J made?
KLAUSNER ARTHUR J has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does KLAUSNER ARTHUR J trade?
KLAUSNER ARTHUR J has filed SEC Form 4 disclosures for 1 company, including MNPR.
When was KLAUSNER ARTHUR J's most recent SEC Form 4 filing?
KLAUSNER ARTHUR J's most recent SEC Form 4 filing on Tracefour is dated Dec 19, 2025.
What is KLAUSNER ARTHUR J's total buy and sell value in the current window?
Inside the rolling retention window, KLAUSNER ARTHUR J bought $0 and sold $344K based on SEC Form 4 filings.
What was KLAUSNER ARTHUR J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,121 MNPR shares on 2025-12-18, worth $344K, per SEC Form 4 filings.